189 related articles for article (PubMed ID: 33781090)
1. Fabrication of Mupirocin-Loaded Nanostructured Lipid Carrier and Its
Singh AP; Sharma SK; Gaur PK; Gupta DK
Assay Drug Dev Technol; 2021; 19(4):216-225. PubMed ID: 33781090
[No Abstract] [Full Text] [Related]
2. Development, characterization and pharmacokinetics of mupirocin-loaded nanostructured lipid carriers (NLCs) for intravascular administration.
Alcantara KP; Zulfakar MH; Castillo AL
Int J Pharm; 2019 Nov; 571():118705. PubMed ID: 31536765
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Activity of Nanostructured Lipid Carriers Loaded
Fathi N; Lotfipour F; Dizaj SM; Hamishehkar H; Mohammadi M
Pharm Nanotechnol; 2020; 8(6):485-494. PubMed ID: 33407060
[TBL] [Abstract][Full Text] [Related]
4. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
5. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
Rathod VR; Shah DA; Dave RH
Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers incorporating prickly pear seed oil for the encapsulation of vitamin A.
AlZahabi S; Sakr OS; Ramadan AA
J Cosmet Dermatol; 2019 Dec; 18(6):1875-1884. PubMed ID: 30784168
[TBL] [Abstract][Full Text] [Related]
7. Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery.
Varela-Fernández R; García-Otero X; Díaz-Tomé V; Regueiro U; López-López M; González-Barcia M; Isabel Lema M; Javier Otero-Espinar F
Eur J Pharm Biopharm; 2022 Mar; 172():144-156. PubMed ID: 35183717
[TBL] [Abstract][Full Text] [Related]
8. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers.
Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X
AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.
Safwat S; Ishak RAH; Hathout RM; Mortada ND
Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784
[TBL] [Abstract][Full Text] [Related]
10. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin.
Zhang K; Lv S; Li X; Feng Y; Li X; Liu L; Li S; Li Y
Int J Nanomedicine; 2013; 8():3227-39. PubMed ID: 24009420
[TBL] [Abstract][Full Text] [Related]
12. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
Zafar A
J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
[TBL] [Abstract][Full Text] [Related]
13. Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line.
Kamel AE; Fadel M; Louis D
Int J Nanomedicine; 2019; 14():5073-5085. PubMed ID: 31371948
[TBL] [Abstract][Full Text] [Related]
14. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
Rizwanullah M; Amin S; Ahmad J
J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
[TBL] [Abstract][Full Text] [Related]
15. Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs).
Sanad RA; Abdelmalak NS; Elbayoomy TS; Badawi AA
AAPS PharmSciTech; 2010 Dec; 11(4):1684-94. PubMed ID: 21107771
[TBL] [Abstract][Full Text] [Related]
16. Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.
Vieira R; Severino P; Nalone LA; Souto SB; Silva AM; Lucarini M; Durazzo A; Santini A; Souto EB
Molecules; 2020 Feb; 25(3):. PubMed ID: 32041134
[TBL] [Abstract][Full Text] [Related]
17. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine.
Zhou L; Chen Y; Zhang Z; He J; Du M; Wu Q
Pharmazie; 2012 Apr; 67(4):304-10. PubMed ID: 22570936
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.
Paudel A; Ameeduzzafar ; Imam SS; Fazil M; Khan S; Hafeez A; Ahmad FJ; Ali A
Curr Drug Deliv; 2017; 14(7):1005-1015. PubMed ID: 28034361
[TBL] [Abstract][Full Text] [Related]
19. Nanostructured lipid carriers for the topical delivery of tretinoin.
Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
[TBL] [Abstract][Full Text] [Related]
20. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Sathe P; Saka R; Kommineni N; Raza K; Khan W
Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]